BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12814641)

  • 1. The chemical biology of branched-chain lipid metabolism.
    Mukherji M; Schofield CJ; Wierzbicki AS; Jansen GA; Wanders RJ; Lloyd MD
    Prog Lipid Res; 2003 Sep; 42(5):359-76. PubMed ID: 12814641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human metabolism of phytanic acid and pristanic acid.
    Verhoeven NM; Jakobs C
    Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
    Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
    J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of phytanic acid and pristanic acid in man: a review.
    Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
    J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.
    Van Veldhoven PP
    J Lipid Res; 2010 Oct; 51(10):2863-95. PubMed ID: 20558530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytanic acid metabolism in health and disease.
    Wanders RJ; Komen J; Ferdinandusse S
    Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytanic acid: production from phytol, its breakdown and role in human disease.
    van den Brink DM; Wanders RJ
    Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-oxidation.
    Jansen GA; Wanders RJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1403-12. PubMed ID: 16934890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders.
    Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
    Adv Exp Med Biol; 2020; 1299():55-70. PubMed ID: 33417207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
    Poulos A; Sharp P; Fellenberg AJ; Johnson DW
    Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisomes contain a specific phytanoyl-CoA/pristanoyl-CoA thioesterase acting as a novel auxiliary enzyme in alpha- and beta-oxidation of methyl-branched fatty acids in mouse.
    Westin MAK; Hunt MC; Alexson SEH
    J Biol Chem; 2007 Sep; 282(37):26707-26716. PubMed ID: 17613526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
    Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
    Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals.
    Mannaerts GP; Van Veldhoven PP; Casteels M
    Cell Biochem Biophys; 2000; 32 Spring():73-87. PubMed ID: 11330072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemistry of peroxisomes in health and disease.
    Singh I
    Mol Cell Biochem; 1997 Feb; 167(1-2):1-29. PubMed ID: 9059978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
    Wierzbicki AS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
    Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [alpha-Oxidation of 3-methyl-branched fatty acids: unraveling of a pathway].
    Casteels M
    Verh K Acad Geneeskd Belg; 2006; 68(3):199-221; discussion 221-2. PubMed ID: 16796018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.